Low Ferritin on TRT & GLP-1s: Depletion or Marker Shift?
Testosterone pulls stored iron into new red cells. GLP-1 drugs cut food intake. And ferritin also tracks inflammation and liver fat. Here is what the studies actually support, and what they do not.
Build your own printable peptide tracker
A personalized injection log, weekly dosing schedule and dated calendar — your compounds filled in, ready to print. Free to build and preview; $5/month to unlock printing.

How It Works
Hepcidin is the hormone that locks iron away. In a 20-week dosing study, high testosterone levels markedly suppressed serum hepcidin within one week, and the suppression was dose-dependent and stronger in older men (PMID 20660052). Hepcidin limits iron release from the gut and storage cells (PMID 42700347), so less hepcidin frees more iron for use. The effect is a suppression, not a permanent off-switch: in older men on testosterone gel, hepcidin fell at 1 and 3 months but returned toward baseline by 6 months despite continued testosterone (PMID 24158761).
In older men on testosterone gel, hemoglobin rose about 7% and hematocrit about 10%, while ferritin and hepcidin fell at 1 and 3 months and soluble transferrin receptor rose, consistent with increased iron use for red-cell production (PMID 24158761). In the TRAVERSE anemia trial, TRT corrected anemia more often than placebo (PMID 37889486).
A 2026 review of six studies covering 480,825 adults found GLP-1 RA users had 26–30% lower ferritin than SGLT2 inhibitor users, and more than 60% of users ate below estimated iron requirements. The authors proposed appetite suppression, delayed gastric emptying and altered absorption as mechanisms, but stressed causality cannot be established from observational data (PMID 41549912).
Ferritin is not a pure iron gauge. In 628 biopsy-proven NAFLD patients, ferritin above 1.5× the upper limit of normal was tied to NASH and more advanced fibrosis (PMID 21953442). In obesity, inflammation drives hepcidin up, and weight loss appears to lower inflammation and hepcidin (PMID 42700347). Whether GLP-1 ferritin drops reflect this has not been shown in humans (PMID 42559859).
What the Data Shows
Is it depletion or a marker shift?
Ferritin alone cannot answer this. A 2026 review of obesity and iron metabolism recommends reading ferritin next to an inflammation marker such as CRP, supported by transferrin saturation, soluble transferrin receptor or reticulocyte hemoglobin (PMID 42700347). A 2026 hematology review of the diagnostic approach to abnormal ferritin adds that the sTfR/log-ferritin index helps separate iron deficiency from anemia of inflammation, although sTfR is itself influenced by inflammation (PMID 42559859).
Iron being used up
Low ferritin alongside markers of iron-hungry red-cell production. In older men on testosterone gel, ferritin fell while soluble transferrin receptor and the sTfR/log-ferritin ratio rose, consistent with more iron going into new red cells (PMID 24158761).
Ferritin coming down from an inflamed baseline
Ferritin runs high with inflammation and fatty liver disease (PMID 21953442; PMID 42700347), so a falling number is not automatically lost iron. Whether that is what happens on GLP-1 drugs is unproven: a 2026 review notes GLP-1 drugs may alter ferritin interpretation, but dedicated human evidence is still insufficient (PMID 42559859).
Key Takeaways
- Testosterone suppresses hepcidin in men, within about a week at high doses (PMID 20660052).
- On testosterone gel, ferritin fell at 1 and 3 months while hemoglobin and hematocrit rose, consistent with stored iron being used for red cells (PMID 24158761).
- TRT corrected anemia in more hypogonadal men than placebo in the TRAVERSE substudy: 41.0% vs 27.5% at 6 months (PMID 37889486).
- Observational data link GLP-1 RA use to 26–30% lower ferritin than SGLT2 inhibitor use, and many users eat below iron requirements (PMID 41549912).
- Ferritin rises with inflammation and fatty liver disease, so it should be read alongside CRP and transferrin saturation (PMID 21953442; PMID 42700347).
- Semaglutide 0.4 mg resolved NASH without worsening fibrosis in 59% of patients vs 17% on placebo in a phase 2 trial (PMID 33185364).
- Whether GLP-1 drugs cause iron deficiency: the evidence is observational and causality is not established (PMID 41549912).
- Whether a ferritin drop on GLP-1s reflects less inflammation or liver fat rather than lost iron: dedicated human evidence is insufficient (PMID 42559859).
- How common low ferritin actually is in people on retatrutide: none of the sources here report data on it.
- Whether the testosterone findings apply to women on HRT: the hepcidin and ferritin studies cited here enrolled men.
- What happens to ferritin when TRT and a GLP-1 are combined: no study cited here tested the combination.
Frequently Asked Questions
Why does ferritin drop on TRT?
Testosterone suppresses hepcidin, the hormone that keeps iron locked in storage, and stimulates red-cell production. In older men on testosterone gel, ferritin fell at 1 and 3 months while hemoglobin rose about 7% and soluble transferrin receptor increased, consistent with stored iron being pulled into new red cells (PMID 24158761; PMID 20660052).
Do GLP-1 drugs like semaglutide or tirzepatide lower ferritin?
Observational data suggest an association. A 2026 narrative review reported 26–30% lower ferritin in GLP-1 receptor agonist users than in SGLT2 inhibitor users, with most users eating below iron requirements. The authors proposed reduced intake and slower gastric emptying as causes, but noted causality cannot be established from these datasets (PMID 41549912).
Is low ferritin on a GLP-1 just inflammation or liver fat going down?
Possibly for some people, but it is unproven. Ferritin runs high with inflammation and fatty liver disease, and in obesity, weight loss appears to reduce inflammation and hepcidin (PMID 21953442; PMID 42700347). A 2026 diagnostic review of hyperferritinemia (high ferritin) says GLP-1 drugs may alter ferritin interpretation, but dedicated human evidence is insufficient (PMID 42559859).
What labs help tell real iron depletion apart from a marker shift?
Reviews recommend not reading ferritin alone. Pair it with an inflammation marker such as CRP, and add transferrin saturation, soluble transferrin receptor or reticulocyte hemoglobin as context requires (PMID 42700347). The sTfR/log-ferritin index can help separate iron deficiency from anemia of inflammation (PMID 42559859). Review results with your clinician.
Does TRT cause anemia or fix it?
In the TRAVERSE anemia substudy of 5,204 hypogonadal men, testosterone gel corrected anemia more often than placebo (41.0% vs 27.5% at 6 months), and fewer non-anemic men on TRT developed anemia (PMID 37889486). In a separate trial, the ferritin drop on testosterone came with signs of increased iron use for red-cell production (PMID 24158761).
🔬 Research-Grade Source
Swiss Chems publishes third-party HPLC COAs for selected products — vendor-published, a claim to verify. HighPeptides' primary vendor reference for peptides.
Browse Swiss Chems →Affiliate links — support HighPeptides at no extra cost.
🛒 Recommended Products
Support supplements and gear relevant to this protocol.
Affiliate links — support HighPeptides at no extra cost.
📚 Related HighPeptides Research
Peer-Reviewed References
Educational purposes only. Not medical advice.
Low ferritin has many causes. Interpret iron labs with a qualified clinician before changing any medication or starting iron.